Lupin and Natco Win U.S. FDA Approval for Eribulin Injection
MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...
Lupin
Advertisement
Lupin Receives US FDA EIR for Ankleshwar Manufacturing Site
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
Lupin Wins U.S. FDA Approval for Famotidine Injection
MUMBAI, India and NAPLES, Fla., May 13, 2026 Global pharmaceutical company Lupin Limited announced that it has received approval...
Lupin Wins FDA Approval for UCD Oral Liquid Drug
MUMBAI, India & NAPLES, Fla., May 5, 2026 Lupin Limited, a global pharmaceutical leader, has announced that it has...
Lupin Launches Dapagliflozin Tablets in U.S. Market
Mumbai, India & Naples, Florida | April 10, 2026 Lupin Limited has announced the U.S. launch of Dapagliflozin Tablets...
Advertisements
Lupin Gains US FDA Nod for Dapagliflozin Tablets
MUMBAI, India and NAPLES, Fla., April 7, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
Lupin Gains FDA Nod for Sugammadex Injection in US
MUMBAI, India & NAPLES, Fla., USA, March 31, 2026 Lupin Limited has received tentative approval from the U.S. Food...
Lupin Gets FDA Nod for Pitolisant Tablets
MUMBAI, INDIA & NAPLES, USA | March 25, 2026 Lupin Limited, a global pharmaceutical leader, has received tentative approval...
FDA Supports Consegna CP217 for Opioid Overdose Care
February 24, 2026 – Pittsburgh, Pennsylvania, USA Consegna Pharma, Inc. has announced that the U.S. Food and Drug Administration...
Lupin Launches Brivaracetam Oral Solution in US
February 24, 2026 – Mumbai, India & Naples, Florida, USA Global pharmaceutical leader Lupin Limited has announced that it...
Advertisement
